The expanding demand for controlled immunological study and therapeutic design has spurred significant advances in recombinant cytokine manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently produced using multiple expression methods, including microbial hosts, animal cell cultures, and viral replicati